Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines

Bioorganic & Medicinal Chemistry Letters
2006.0

Abstract

We report herein the SAR studies of a series of indole-imidazole compounds. that demonstrate substantial in vitro anti-proliferative activities against cancer cell lines, including multidrug resistance (MDR) phenotypes. The in vitro cytotoxic effects have been demonstrated across a wide array of tumor types, including hematologic and solid tumor cell lines of various origins (e.g., leukemia, breast, colon, and uterine).

Knowledge Graph

Similar Paper

Conjugated indole-imidazole derivatives displaying cytotoxicity against multidrug resistant cancer cell lines
Bioorganic & Medicinal Chemistry Letters 2006.0
Indole- and indolizine-glyoxylamides displaying cytotoxicity against multidrug resistant cancer cell lines
Bioorganic & Medicinal Chemistry Letters 2008.0
Design, synthesis and structure–activity relationship (SAR) studies of imidazo[4,5-b]pyridine derived purine isosteres and their potential as cytotoxic agents
European Journal of Medicinal Chemistry 2015.0
Synthesis and cytotoxic activity of novel hexahydropyrrolo[2,3- b ]indole imidazolium salts
Bioorganic & Medicinal Chemistry Letters 2016.0
New (3-(1H-benzo[d]imidazol-2-yl))/(3-(3H-imidazo[4,5-b]pyridin-2-yl))-(1H-indol-5-yl)(3,4,5-trimethoxyphenyl)methanone conjugates as tubulin polymerization inhibitors
MedChemComm 2017.0
Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel benzimidazole–pyrimidine conjugates as potent antitumor agents
European Journal of Medicinal Chemistry 2010.0
Novel 6,7-diphenyl-2,3,8,8a-tetrahydro-1H-indolizin-5-one analogues as cytotoxic agents
Bioorganic & Medicinal Chemistry Letters 2003.0
Synthesis of new conjugated coumarin–benzimidazole hybrids and their anticancer activity
Bioorganic & Medicinal Chemistry Letters 2013.0
Design, synthesis, and cytotoxic activities of new 2,4,5-triarylimidazoles
Medicinal Chemistry Research 2013.0